Use of C2-substituted Indane-1-one systems for producing medicaments for the prophylaxis or treatment of obesity

Details for Australian Patent Application No. 2002336985 (hide)

International Classifications

Event Publications

20 February 2003 Complete Application Filed

Priority application(s): 101 42 668,2 31.08.01 DE

5 June 2003 Application Open to Public Inspection

Published as AU-B-2002336985

22 December 2005 Assignment before Grant

Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

16 November 2006 Application Accepted

Published as AU-B-2002336985

15 March 2007 Standard Patent Sealed

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.